Naptumomab Biosimilar - Research Grade

Naptumomab Biosimilar - Research Grade, Human IgG1-Kappa

Target: 5T4.

Specificity: Detects human 5T4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Naptumomab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Naptumomab is a fusion protein consisting of the antigen-binding fragment (Fab) of a monoclonal antibody with the superantigen staphylococcal enterotoxin A (SEA/E-120, "estafenatox"). The Fab binds to 5T4, an antigen expressed by various tumor cells, and the superantigen induces an immune response by activating T lymphocytes.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE.

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• Artikelnummer: ICH5007-50MG
• Hersteller: Ichorbio
• Hersteller Artikelnummer: ICH5007-50MG
• Verpackungseinheit: 50mg
• Mengeneinheit: STK
• Reaktivität: Human
• Klonalität: Monoclonal
• Methode: Functional Assay
• Isotyp: Human IgG1-Kappa